Summit Therapeutics PLC logo

Summit Therapeutics PLC

LSE:SUMM (USA)  
£ 0.21 (0%) Feb 21
At Loss
P/B:
42.25
Market Cap:
£ 68.91M ($ 86.50M)
Enterprise V:
£ 4.95M ($ 6.22M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Summit Therapeutics PLC Valuation Measures